Semliki Forest Virus-Based Expression of Recombinant GPCRs

被引:0
|
作者
Lundstrom, Kenneth [1 ]
机构
[1] PanTherapeutics, Lutry, Switzerland
关键词
PROTEIN-COUPLED RECEPTOR; HIGH-LEVEL EXPRESSION; SINDBIS VIRUS; CELL-LINES; PHARMACOLOGICAL CHARACTERIZATION; MAMMALIAN-CELLS; GENE-EXPRESSION; 5-HT3; RECEPTOR; IN-VITRO; VECTORS;
D O I
10.1016/bs.mie.2014.11.047
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Due to their importance as targets for drug development, rapid and consistent high-level production of G protein-coupled receptors (GPCRs) has become an essential part of drug discovery. Alphaviruses, particularly recombinant Semliki Forest virus (SFV) particles, have provided the means for expression of a number of GPCRs in a broad range of mammalian host cell lines for pharmacological characterization by determination of receptor binding activity and functional coupling to G proteins. The rapid high-titer virus particle production has made it possible to study a large number of GPCRs in parallel. Moreover, large-scale production in adherent and suspension cultures of mammalian cells has provided sufficient amounts of GPCRs for purification and subsequent structural studies. Furthermore, the high preference for neuronal delivery of SFV particles has allowed functional and localization studies of recombinant proteins in hippocampal slice cultures, in primary neurons, and in vivo.
引用
收藏
页码:331 / 350
页数:20
相关论文
共 50 条
  • [1] Semliki Forest virus-based immunotherapy for cancer
    Lundstrom, Kenneth
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (06) : 593 - 599
  • [2] Semliki forest virus-based expression for versatile use in receptor research
    Lundstrom, K
    JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 2002, 22 (1-4): : 229 - 240
  • [3] Semliki Forest virus-based DNA expression vector: transient protein production followed by cell death
    Kohno, A
    Emi, N
    Kasai, M
    Tanimoto, M
    Saito, H
    GENE THERAPY, 1998, 5 (03) : 415 - 418
  • [4] Semliki Forest virus-based DNA expression vector: transient protein production followed by cell death
    A Kohno
    N Emi
    M Kasai
    M Tanimoto
    H Saito
    Gene Therapy, 1998, 5 : 415 - 418
  • [5] Recombinant protein production using the Semliki Forest Virus expression system
    H.D. Blasey
    K. Lundström
    S. Tate
    A.R. Bernard
    Cytotechnology, 1997, 24 : 65 - 72
  • [6] Recombinant protein production using the Semliki Forest Virus expression system
    Blasey, HD
    Lundstrom, K
    Tate, S
    Bernard, AR
    CYTOTECHNOLOGY, 1997, 24 (01) : 65 - 72
  • [7] Human MxA protein confers resistance to semliki forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins
    Landis, H
    Simon-Jödicke, A
    Klöti, A
    Di Paolo, C
    Schnorr, JJ
    Schneider-Schaulies, S
    Hefti, HP
    Pavlovic, J
    JOURNAL OF VIROLOGY, 1998, 72 (02) : 1516 - 1522
  • [8] SEMLIKI FOREST VIRUS EXPRESSION SYSTEM - PRODUCTION OF CONDITIONALLY INFECTIOUS RECOMBINANT PARTICLES
    BERGLUND, P
    SJOBERG, M
    GAROFF, H
    ATKINS, GJ
    SHEAHAN, BJ
    LILJESTROM, P
    BIO-TECHNOLOGY, 1993, 11 (08): : 916 - 920
  • [9] Immunogenicity of Recombinant Semliki Forest Virus-based RNA Vaccines Expressing HIV-1 Indian Subtype C Antigens in Mice
    Ajbani, Seema
    Velhal, Shilpa
    Kadam, Ravindra
    Patel, Vainav
    Bandivdekar, Atmaram
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A240 - A240
  • [10] EXPRESSION OF SEMLIKI FOREST VIRUS CAPSID PROTEIN FROM SV40 RECOMBINANT VIRUS
    JALANKO, A
    FEBS LETTERS, 1985, 186 (01): : 59 - 64